INC280 and Erlotinib Hydrochloride in Treating Patients With Non-small Cell Lung Cancer
Clinical trial NCT01911507 · COMPLETED
Trial details
- NCT number
- NCT01911507
- Sponsor
- University of California, Davis
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-27
- Primary completion
- 2020-08-26
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.